Form 4: Guardant Health Director Tariq Musa Acquires Stock Options and Restricted Stock Units

Director Tariq Musa of Guardant Health, Inc. reports acquisition of stock options and restricted stock units.

Summary

• On June 12, 2024, Tariq Musa, a director of Guardant Health, Inc., acquired 10,703 stock options with an exercise price of $31.84.
• These options vest fully on the one-year anniversary of the grant date or the date of the next annual stockholders meeting, whichever is earlier, and expire on June 12, 2034.
• Musa also acquired 6,674 restricted stock units (RSUs) which vest fully on the one-year anniversary of the grant date or the date of the next annual stockholders meeting, whichever is earlier.
• Following these transactions, Musa directly owns 10,703 stock options and 6,674 RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock options and restricted stock units granted to a director. The acquisition itself can be seen as a positive sign, but it's a routine part of executive compensation.

Positives

• The acquisition of stock options and restricted stock units by a director signals confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be indicative of their confidence in the company's prospects.

Stakeholder Impact

• The acquisition of stock options and restricted stock units by a director can positively influence shareholder sentiment.

Key Dates